Tze Tec Chong

Tze Tec Chong

Auto-generated profile, based on publicly available information

Tze Tec Chong

Department of Vascular Surgery, Singapore General Hospital, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
IWIan Jun Yan Wee
Ian Jun Yan Wee
HYHao Yun Yap
Hao Yun Yap
LTLuke Tay Hsien Ts'UNg
Luke Tay Hsien Ts'UNg
SQShaun Lee Qingwei
Shaun Lee Qingwei
CTChieh Suai Tan
Chieh Suai Tan
TCTze Tec Chong
Tze Tec Chong

1 January 2020 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
IWIan Jun Yan Wee
Ian Jun Yan Wee
HYHao Yun Yap
Hao Yun Yap
TTTjun Yip Tang
Tjun Yip Tang
TCTze Tec Chong
Tze Tec Chong

1 September 2021 in Radiology
Verified
Journal Article
Closed access
APAnkur Patel
Ankur Patel
FIFarah G. Irani
Farah G. Irani
UPUei Pua
Uei Pua
KTKiang Hiong Tay
Kiang Hiong Tay
TCTze Tec Chong
Tze Tec Chong
BTBien Soo Tan
Bien Soo Tan
Drug-coated balloons in below-the-knee arteries in patients with critical limb ischemia conferred no benefit over conventional balloon angioplasty in 6-month primary patency, with poorer amputation... Background There is a paucity of randomized trials demonstrating superior efficacy of drug-coated balloon angioplasty (DCBA) compared with conventional percutaneous transluminal angioplasty (PTA) f...

27 March 2018 in The Journal of Vascular Access
Verified
Journal Article
Closed access
HYHao-Yun Yap
Hao-Yun Yap
SPSuh-Chien Pang
Suh-Chien Pang
CTChieh-Suai Tan
Chieh-Suai Tan
YTYi-Liang Tan
Yi-Liang Tan
NGNicholette Goh
Nicholette Goh
TCTze-Tec Chong
Tze-Tec Chong
Hemodialysis is the main modality of renal replacement therapy in Singapore. However, a majority of the patients in Singapore are initiated on hemodialysis via a catheter. This study examines the complication rates and factors predicting catheter-related bloodstream infections and mortality rates in patients who were initiated on hemodialysis at our institution. This is a single-center retrospective analysis of incident hemodialysis patients who were initiated on renal replacement therapy between 1 January 2010 and 31 December 2012. Catheter-related bloodstream infection risk factors, organisms, and associated mortality were analyzed. The catheter-related bloodstream infection and exit site infection incidence rates were 0.75 and 0.50 per 1000 catheter days, respectively. The mean duration to first catheter-related bloodstream infection episode was 182.47 ± 144.04 catheter days. Prolonged catheter duration was found to be a risk factor for catheter-related bloodstream infection. Compared to patients initiated on dialysis via arteriovenous fistula, initiation of dialysis via catheter is strongly associated with increased mortality (6.0% vs 14.5%; p = 0.02). In particular, the presence of diabetes mellitus and development of catheter-related bloodstream infection was associated with increased mortality (p = 0.04 and 0.05, respectively). In addition, patients who began hemodialysis before being seen by a nephrologist were associated with decreased mortality (3.4% vs 13.0%; p = 0.03). In conclusion, prolonged duration of catheter insertion is found to be a risk factor for catheter-related bloodstream infection in hemodialysis patients, and its development is associated with increased mortality. Early referral to a nephrologist and creation of arteriovenous fistula in pre-end-stage renal disease patients are pivotal in improving the outcomes of patients.

11 June 2021 in Vascular Specialist International
Verified
Journal Article
Open access
PDF file
SSShereen X. Y. Soon
Shereen X. Y. Soon
APAnkur Patel
Ankur Patel
TCTze Tec Chong
Tze Tec Chong
CYCharyl Yap
Charyl Yap
HTHsien Ts'UNg Tay
Hsien Ts'UNg Tay
TTTjun Yip Tang
Tjun Yip Tang
Shereen X. Y. Soon, Ankur Patel, Tze Tec Chong, Charyl J. Q. Yap, Hsien Ts’ung Tay, Kiang Hiong Tay, Chandramohan Sivanathan, and Tjun Y. Tang. Vasc Specialist Int 2021;37:. https://doi.org/10.5758/vsi.210016

Verified
Journal Article
Open access
PDF file
XWXiaomeng Wang
Xiaomeng Wang
YNYing-Hwey Nai
Ying-Hwey Nai
JGJulian Gan
Julian Gan
CLCheryl Pei Ling Lian
Cheryl Pei Ling Lian
FRFraser Kirwan Ryan
Fraser Kirwan Ryan
DHDerek Hausenloy
Derek Hausenloy
Peripheral artery disease (PAD) is a common and debilitating condition characterized by the narrowing of the limb arteries, primarily due to atherosclerosis. Non-invasive multi-modality imaging approaches using computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging have emerged as valuable tools for assessing PAD atheromatous plaques and vessel walls. This review provides an overview of these different imaging techniques, their advantages, limitations, and recent advancements. In addition, this review highlights the importance of molecular markers, including those related to inflammation, endothelial dysfunction, and oxidative stress, in PAD pathophysiology. The potential of integrating molecular and imaging markers for an improved understanding of PAD is also discussed. Despite the promise of this integrative approach, there remain several challenges, including technical limitations in imaging modalities and the need for novel molecular marker discovery and validation. Addressing these challenges and embracing future directions in the field will be essential for maximizing the potential of molecular and imaging markers for improving PAD patient outcomes.